Stockreport

Emmaus Life Sciences Receives Notice of Nasdaq Delisting Following Merger with MYnd Analytics

EMMAUS LIFE SCIENCES INC  (EMMA) 
PDF TORRANCE, Calif., July 22, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (Nasdaq: EMMA), a leader in sickle cell disease treatment, announced today that it received a [Read more]